SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers
NCT05408936
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
SGLT2 inhibitor
Sponsor
University of Patras